FDA pledges to work with drug makers on shortages
This article was originally published in Scrip
Executive Summary
Even though the number of drug shortages has dropped in the past two years – attributed largely to a law enacted in 2012 that imposed new notification requirements on biopharmaceutical makers – there are still critical medicines for which there are shortfalls, said Captain Valerie Jensen, an officer in the US Public Health Service and the associate director of the FDA's Drug Shortage Program.